PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+7.35%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(+1.9%)
Cap. Flow
-$3.2M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
34.97%
Holding
113
New
8
Increased
24
Reduced
31
Closed
7
Top Buys
| 1 |
SRXH
SRX Health Solutions, Inc.
SRXH
|
$1.29M |
| 2 |
Achieve Life Sciences
ACHV
|
$1.18M |
| 3 |
ASPU
ASPEN GROUP, INC.
ASPU
|
$1.15M |
| 4 |
BIOL
Biolase, Inc.
BIOL
|
$1.02M |
| 5 |
Perion Network
PERI
|
$811K |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$4.02M |
| 2 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$1.92M |
| 3 |
SHSP
SharpSpring, Inc.
SHSP
|
$1.79M |
| 4 |
Sonim Technologies
SONM
|
$1.49M |
| 5 |
INTZ
INTRUSION INC NEW
INTZ
|
$1.4M |
Sector Composition
| 1 | Healthcare | 61.86% |
| 2 | Technology | 15.69% |
| 3 | Communication Services | 6.71% |
| 4 | Industrials | 5.33% |
| 5 | Consumer Staples | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Castle Biosciences
CSTL
$673M
| $2.43M | 1.38% |
33,150
-350
| -1% | -$25.7K |
|
|
27
Perion Network
PERI
$418M
| $2.4M | 1.36% |
111,851
+37,851
| +51% | +$811K |
|
|
ATRS
28
DELISTED
Antares Pharma, Inc.
ATRS
| $2.36M | 1.34% |
541,783
-500
| -0.1% | -$2.18K |
|
|
VG
29
DELISTED
Vonage Holdings Corporation
VG
| $2.28M | 1.3% |
158,525
+2,500
| +2% | +$36K |
|
|
BIOL
30
DELISTED
Biolase, Inc.
BIOL
| $2.18M | 1.24% |
3,122,850
+1,467,350
| +89% | +$1.02M |
|
|
CSII
31
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.13M | 1.21% |
49,942
-825
| -2% | -$35.2K |
|
|
ASPU
32
DELISTED
ASPEN GROUP, INC.
ASPU
| $2.1M | 1.19% |
321,250
+176,000
| +121% | +$1.15M |
|
33
Pfizer
PFE
$141B
| $1.99M | 1.13% |
50,848
+1,920
| +4% | +$75.2K |
|
|
AKTS
34
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $1.95M | 1.11% |
182,200
+8,750
| +5% | +$93.7K |
|
35
Target
TGT
$42B
| $1.89M | 1.07% |
7,829
| – | – |
|
|
PFIE
36
DELISTED
Profire Energy, Inc
PFIE
| $1.78M | 1.01% |
1,572,260
-56,620
| -3% | -$64K |
|
37
QuickLogic
QUIK
$80.7M
| $1.75M | 0.99% |
241,785
+8,000
| +3% | +$57.8K |
|
|
ZIXI
38
DELISTED
Zix Corporation
ZIXI
| $1.62M | 0.92% |
230,175
-2,500
| -1% | -$17.6K |
|
|
XLNX
39
DELISTED
Xilinx Inc
XLNX
| $1.56M | 0.89% |
10,795
| – | – |
|
|
40
Achieve Life Sciences
ACHV
$146M
| $1.55M | 0.88% |
172,100
+131,500
| +324% | +$1.18M |
|
41
Elutia
ELUT
$84.4M
| $1.48M | 0.84% |
154,425
+15,500
| +11% | +$149K |
|
42
AbbVie
ABBV
$374B
| $1.39M | 0.79% |
12,313
| – | – |
|
43
Perspective Therapeutics
CATX
$251M
| $1.32M | 0.75% |
1,654,000
+255,000
| +18% | +$204K |
|
44
3M
MMM
$81B
| $1.3M | 0.74% |
6,556
| – | – |
|
|
SRXH
45
SRX Health Solutions, Inc.
SRXH
$13.3M
| $1.29M | 0.73% |
+300,000
| New | +$1.29M |
|
46
Agrify
AGFY
| $1.26M | 0.72% |
106,250
-6,750
| -6% | -$108K |
|
47
AT&T
T
$208B
| $1.18M | 0.67% |
40,979
+327
| +0.8% | +$9.41K |
|
|
PDCO
48
DELISTED
Patterson Companies, Inc.
PDCO
| $1.12M | 0.64% |
36,950
+7,575
| +26% | +$230K |
|
49
Bristol-Myers Squibb
BMY
$96.7B
| $1.1M | 0.62% |
16,450
| – | – |
|
50
Gilead Sciences
GILD
$140B
| $1.06M | 0.6% |
15,400
+3,100
| +25% | +$213K |
|